Emerging Concepts in Pathogenesis, Multiomics Applications, and Clinical Research in Lymphangioleiomyomatosis

Area of Science:

• Pulmonary Medicine
• Oncology
• Rare Diseases

Background:

• Lymphangioleiomyomatosis (LAM) is a rare, female-predominant neoplasm.
• Characterized by abnormal smooth muscle-like cell infiltration in the lungs, leading to cystic changes and respiratory failure.

Purpose of the Study:

• To highlight recent advancements in Lymphangioleiomyomatosis (LAM) research and clinical care.
• To emphasize the collaborative efforts driving progress in rare lung diseases.

Main Methods:

• Review of recent developments in LAM research and clinical practice.
• Integration of bioinformatics and experimental approaches.

Main Results:

• Development of an FDA-approved therapy for LAM.
• Establishment of a diagnostic biomarker and a global clinical network.
• Creation of clinical practice guidelines for LAM management.

Conclusions:

• LAM serves as a model for rare lung disease progress.
• Ongoing research promises novel biomarkers and therapies for LAM in the near future.